JANKOWSKI ORION D.,WESSON KIERON E.,MOLLARD PAUL,SHRADER WILLIAM D.,JANKOWSKI Orion D.,WESSON Kieron E.,MOLLARD Paul,SHRADER William D.
申请号：
SI200831577
公开号：
SI2220030T1
申请日:
2008.11.04
申请国别(地区):
SI
年份:
2016
代理人:
摘要：
The present invention provides specific 4-(p-quinonyl)-2-hydroxybutanamide derivative compounds, pharmaceutical compositions comprising them, and those compounds and compositions for use methods of treating or suppressing a mitochondrial disorder, modulating one or more energy biomarkers, normalizing one or more energy biomarkers, or enhancing one or more energy biomarkers, and treating a subject suffering from a pervasive developmental disorder selected from the group consisting of Autistic Disorder, Asperger's Disorder, Childhood Disintegrative Disorder (CDD), Rett's Disorder, and Pervasive Developmental Disorder-Not Otherwise Specified (PDD-NOS).
